IRF4: Immunity. Malignancy! Therapy?

被引：160

作者：

Shaffer, Arthur L. ^{[1
]}

Emre, N. C. Tolga ^{[1
]}

Romesser, Paul B. ^{[1
,2
]}

Staudt, Louis M. ^{[1
]}

机构：

[1] NCI, Metab Branch, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA

[2] Natl Inst Hlth Res Scholars Program, Howard Hughes Med Inst, Bethesda, MD USA

来源：

CLINICAL CANCER RESEARCH | 2009年 / 15卷 / 09期

基金：

美国国家卫生研究院;

关键词：

B-CELL LYMPHOMA; INTERFERON-REGULATORY FACTOR-4; SEQUENCE-BINDING-PROTEIN; CLASS-SWITCH RECOMBINATION; TRANSCRIPTION FACTOR; MULTIPLE-MYELOMA; GENE-EXPRESSION; KAPPA-B; T-CELLS; TERNARY COMPLEX;

D O I：

10.1158/1078-0432.CCR-08-1845

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IRF4, a member of the Interferon Regulatory Factor (IRF) family of transcription factors, is expressed in cells of the immune system, where it transduces signals from various receptors to activate or repress gene expression. IRF4 expression is a key regulator of several steps in lymphoid-, myeloid-, and dendritic-cell differentiation, including the differentiation of mature B cells into antibody-secreting plasma cells. IRF4 expression is also associated with many lymphoid malignancies, with recent evidence pointing to an essential role in multiple myeloma, a malignancy of plasma cells. Interference with IRF4 expression is lethal to multiple myeloma cells, irrespective of their genetic etiology, making IRF4 an "Achilles' heel" that may be exploited therapeutically.

引用

页码：2954 / 2961

页数：8

共 87 条

[1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[2] Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].

Annunziata, Christina M. ;

Davis, R. Eric ;

Demchenko, Yulia ;

Bellamy, William ;

Gabrea, Ana ;

Zhan, Fenghuang ;

Lenz, Georg ;

Hanamura, Ichiro ;

Wright, George ;

Xiao, Wenming ;

Dave, Sandeep ;

Hurt, Elaine M. ;

Tan, Bruce ;

Zhao, Hong ;

Stephens, Owen ;

Santra, Madhumita ;

Williams, David R. ;

Dang, Lenny ;

Barlogie, Bart ;

Shaughnessy, John D., Jr. ;

Kuehl, W. Michael ;

Staudt, Louis M. .

CANCER CELL, 2007, 12 (02) :115-130

[3] Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma [J].

Barlogie, B ;

Jagannath, S ;

Vesole, DH ;

Naucke, S ;

Cheson, B ;

Mattox, S ;

Bracy, D ;

Salmon, S ;

Jacobson, J ;

Crowley, J ;

Tricot, G .

BLOOD, 1997, 89 (03) :789-793

[4] Tracking CD40 signaling during germinal center development [J].

Basso, K ;

Klein, U ;

Niu, HF ;

Stolovitzky, GA ;

Tu, YH ;

Califano, A ;

Cattoretti, G ;

Dalla-Favera, R .

BLOOD, 2004, 104 (13) :4088-4096

[5] Molecular pathogenesis and a consequent classification of multiple myeloma [J].

Bergsagel, PL ;

Kuehl, WM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6333-6338

[6] Assembly requirements of PU.1-Pip (IRF-4) activator complexes:: inhibiting function in vivo using fused dimers [J].

Brass, AL ;

Zhu, AQ ;

Singh, H .

EMBO JOURNAL, 1999, 18 (04) :977-991

[7] Pip, a lymphoid-restricted IRF, contains regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1 [J].

Brass, AL ;

Kehrli, E ;

Eisenbeis, CF ;

Storb, U ;

Singh, H .

GENES & DEVELOPMENT, 1996, 10 (18) :2335-2347

[8] The development of inflammatory TH-17 cells requires interferon-regulatory factor 4 [J].

Bruestle, Anne ;

Heink, Sylvia ;

Huber, Magdalena ;

Rosenplaenter, Christine ;

Stadelmann, Christine ;

Yu, Philipp ;

Arpaia, Enrico ;

Mak, Tak W. ;

Kamradt, Thomas ;

Lohoff, Michael .

NATURE IMMUNOLOGY, 2007, 8 (09) :958-966

[9] Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance [J].

Cattoretti, Giorgio ;

Shaknovich, Rita ;

Smith, Paula M. ;

Jack, Hans-Martin ;

Murty, Vundavalli V. ;

Alobeid, Bachir .

JOURNAL OF IMMUNOLOGY, 2006, 177 (10) :6930-6939

[10] Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair [J].

Chaudhuri, J ;

Alt, FW .

NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :541-552

← 1 2 3 4 5 6 7 8 9 →